An integrated analysis of the clinical and neuroradiological effect of BG-12 (dimethyl fumarate) in subgroups of patients with relapsing-remitting multiple sclerosis from the phase 3 DEFINE and CONFIRM studies

被引：0
|
作者：
Bar-Or, A.
Fox, R. J.
Gold, R.
Miller, D. H.
Arnold, D. L.
O'Gorman, J.
Yang, M.
Sheikh, S. I.
Viglietta, V.
Dawson, K. T.
Hutchinson, M.
机构：
[1] McGill Univ, Montreal Neurol Inst & Hosp, Montreal, PQ, Canada
[2] Cleveland Clin, Mellen Ctr Multiple Sclerosis Treatment & Res, Cleveland, OH 44106 USA
[3] Ruhr Univ Bochum, St Josef Hosp, Bochum, Germany
[4] UCL, Inst Neurol, NMR Res Unit, London, England
[5] NeuroRx Res, Montreal, PQ, Canada
[6] Biogen Idec Inc, Weston, MA USA
[7] Vincents Univ Hosp, Dublin, Ireland
来源：
JOURNAL OF NEUROLOGY | 2013年 / 260卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
O229
引用
收藏
页码：S13 / S13
页数：1
相关论文
共 50 条
  • [1] CLINICAL AND NEURORADIOLOGICAL EFFECT OF BG-12 (DIMETHYL FUMARATE) IN SUBGROUPS OF PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS): AN INTEGRATED ANALYSIS OF THE PHASE 3 DEFINE AND CONFIRM STUDIES
    Bar-Or, A.
    Fox, R. J.
    Gold, R.
    Miller, D. H.
    Arnold, D. L.
    O'Gorman, J.
    Yang, M.
    Sheikh, S., I
    Viglietta, V.
    Dawson, K. T.
    Hutchinson, M.
    [J]. VALUE IN HEALTH, 2013, 16 (03) : A102 - A102
  • [2] Effect of BG-12 (Dimethyl Fumarate) in Subgroups of Patients with Relapsing-Remitting Multiple Sclerosis: An Integrated Analysis of the Phase 3 DEFINE and CONFIRM Studies
    Bar-Or, Amit
    Fox, Robert
    Gold, Ralf
    Miller, David
    Arnold, Douglas
    O'Gorman, John
    Yang, Minhua
    Sheikh, Sarah
    Viglietta, Vissia
    Dawson, Katherine
    Hutchinson, Michael
    [J]. NEUROLOGY, 2013, 80
  • [3] An integrated analysis of the clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis from the phase 3 DEFINE and CONFIRM studies
    Fox, R. J.
    Miller, D. H.
    Phillips, J. T.
    Arnold, D. L.
    Selmaj, K.
    Yang, M.
    Zhang, R.
    Dawson, K. T.
    Viglietta, V.
    Sheikh, S. I.
    Gold, R.
    [J]. JOURNAL OF NEUROLOGY, 2013, 260 : S74 - S74
  • [4] Effect of BG-12 (Dimethyl Fumarate) in Subgroups of Patients with Relapsing-Remitting Multiple Sclerosis: Findings from Two Phase 3 Studies (DEFINE and CONFIRM)
    Hutchinson, M.
    Bar-Or, A.
    Fox, R. J.
    Gold, R.
    Giovannoni, G.
    Kita, M.
    O'Gorman, J.
    Yang, M.
    Sheikh, S. I.
    Viglietta, V.
    Dawson, K. T.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (05) : 682 - 683
  • [5] Clinical Efficacy of BG-12 (Dimethyl Fumarate) in Relapsing-Remitting Multiple Sclerosis (RRMS): An Integrated Analysis of the Phase 3 DEFINE and CONFIRM Studies
    Fox, Robert
    Miller, David
    Phillips, J. Theodore
    Arnold, Douglas
    Selmaj, Krzysztof
    Yang, Minhua
    Zhang, Ray
    Dawson, Katherine
    Viglietta, Vissia
    Sheikh, Sarah
    Gold, Ralf
    [J]. NEUROLOGY, 2013, 80
  • [6] Clinical effects of BG-12 in subgroups of patients with relapsing-remitting multiple sclerosis: an integrated analysis of the phase 3 DEFINE and CONFIRM studies
    Bar-Or, A.
    Fox, R. J.
    Gold, R.
    Giovannoni, G.
    Kita, M.
    O'Gorman, J.
    Yang, M.
    Sheikh, S. I.
    Viglietta, V.
    Dawson, K. T.
    Hutchinson, M.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 191 - 191
  • [7] Effect of BG-12 (dimethyl fumarate) in newly diagnosed patients with relapsing-remitting multiple sclerosis from the DEFINE and CONFIRM studies
    Gold, R.
    Giovannoni, G.
    Phillips, J. T.
    Fox, R. J.
    Zhang, A.
    Meltzer, L.
    Kurukulasuriya, N. C.
    [J]. JOURNAL OF NEUROLOGY, 2013, 260 : S51 - S51
  • [8] Clinical and Neuroradiologic Efficacy of BG-12 (Dimethyl Fumarate) in US Patients with Relapsing-Remitting Multiple Sclerosis (RRMS): An Integrated Analysis of the Phase 3 DEFINE and CONFIRM Studies
    Kita, Mariko
    Fox, Robert
    Phillips, J. Theodore
    Arnold, Douglas
    Bar-Or, Amit
    Yang, Minhua
    Zhang, Ray
    Dawson, Katherine
    Viglietta, Vissia
    Sheikh, Sarah
    Gold, Ralf
    [J]. NEUROLOGY, 2013, 80
  • [9] Clinical efficacy of BG-12 in relapsing-remitting multiple sclerosis: an integrated analysis of the phase 3 DEFINE and CONFIRM studies
    Gold, R.
    Miller, D. H.
    Phillips, J. T.
    Arnold, D. L.
    Selmaj, K.
    Yang, M.
    Zhang, R.
    Dawson, K. T.
    Viglietta, V.
    Sheikh, S. I.
    Fox, R. J.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 48 - 49
  • [10] Oral BG-12 (dimethyl fumarate) for relapsing-remitting multiple sclerosis: a review of DEFINE and CONFIRM
    Havrdova, Eva
    Hutchinson, Michael
    Kurukulasuriya, Nuwan C.
    Raghupathi, Kartik
    Sweetser, Marianne T.
    Dawson, Katherine T.
    Gold, Ralf
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (15) : 2145 - 2156
12345